Catalysts for Actavis Elizabeth LLC
201 tracked
Jan 29, 2026
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 5, 2026
approval
OXYMORPHONE HYDROCHLORIDE — FDA approval
OXYMORPHONE HYDROCHLORIDE
→
Dec 31, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Dec 23, 2025
approval
OXYCODONE HYDROCHLORIDE AND IBUPROFEN (IBUPROFEN) — FDA approval
Midol
→
Dec 23, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Dec 22, 2025
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 22, 2025
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 22, 2025
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 22, 2025
approval
MORPHINE SULFATE — FDA approval
Kapanol
→
Dec 12, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Nov 12, 2025
approval
OXYMORPHONE HYDROCHLORIDE — FDA approval
OXYMORPHONE HYDROCHLORIDE
→
Oct 21, 2025
approval
DEFERASIROX — FDA approval
DEFERASIROX
→
Oct 21, 2025
approval
DEFERASIROX — FDA approval
DEFERASIROX
→
Oct 21, 2025
approval
DEFERASIROX — FDA approval
DEFERASIROX
→
Oct 21, 2025
approval
DEFERASIROX — FDA approval
DEFERASIROX
→
Oct 21, 2025
approval
DEFERASIROX — FDA approval
DEFERASIROX
→
Oct 21, 2025
approval
DEFERASIROX — FDA approval
DEFERASIROX
→
Oct 1, 2025
approval
MORPHINE SULFATE — FDA approval
Kapanol
→
Sep 30, 2025
approval
FENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approval
choline fenofibrate
→
Apr 11, 2025
approval
MORPHINE SULFATE — FDA approval
Kapanol
→
Feb 21, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Feb 21, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jan 7, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 7, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 21, 2024
approval
OXYCODONE HYDROCHLORIDE AND IBUPROFEN (IBUPROFEN) — FDA approval
Midol
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
MORPHINE SULFATE — FDA approval
Kapanol
→